Company / Current Liabilities per Share
Relay Therapeutics, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.15
FY2025
5-year range
$0.15 / $0.59
FY2021-FY2025
Trend
-61.7%
vs FY2024
Sector context
#196 of 210
Health Care
What the data says
Among 210 Health Care companies, Relay Therapeutics, Inc. is in the top 7% for current liabilities per share. Current Liabilities per Share has fluctuated over the past 7 years, ranging from $0.15 in FY2025 to $3.47 in FY2019.
Based on SEC 10-K filings.
0.15 in FY2025 with a 5-year CAGR of -46.2%.
Improved from $0.25 to $0.15 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -36.3%
- 5-Year CAGR
- -46.2%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 210This company $0.15 Sector average $15.78
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 61.7% year-over-year.
- Ranks #196 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.15 | -61.7% |
| FY2024 | $0.40 | +59.2% |
| FY2023 | $0.25 | -57.5% |
| FY2022 | $0.59 | +117.6% |
| FY2021 | $0.27 | -92.0% |
| FY2020 | $3.38 | -2.8% |
| FY2019 | $3.47 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026